Feline immunodeficiency virus vaccine
US5833993A · kind A · utility
23Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1996 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | Oct 25, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are vaccines containing both a DNA sequence encoding FIV gag protein and a DNA sequence encoding FIV env protein. The gag and env proteins are preferably expressed by baculovirus expression systems containing the DNA sequences encoding the FIV env and gag proteins or in feline herpes virus vectors containing the DNA sequences encoding the FIV env and gag proteins. Also disclosed are combined mucosal/parenteral, mucosal/mucosal and parenteral/parenteral inoculation methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.